Home/PeptiDream/Nobuhiko Ohno
NO

Nobuhiko Ohno

Director, Senior Managing Executive Officer, CFO

PeptiDream

PeptiDream Pipeline

DrugIndicationPhase
PD-1/IL-2Solid TumorsPhase 1/2
PPS-001Undisclosed OncologyPreclinical
177Lu-PNT6555 (w/ Novartis)Small Cell Lung Cancer (DLL3+)Phase 1